vs
BioAge Labs, Inc.（BIOA）与ZW Data Action Technologies Inc.（CNET）财务数据对比。点击上方公司名可切换其他公司
BioAge Labs, Inc.的季度营收约是ZW Data Action Technologies Inc.的1.8倍（$3.1M vs $1.7M），ZW Data Action Technologies Inc.净利率更高（-6.3% vs -842.9%，领先836.6%）
Altos Labs是一家美国生物技术研究企业，主营业务为开发可延缓或逆转人类衰老进程的寿命延长疗法，围绕该方向开发基于诱导多能干细胞的专用细胞疗法。该公司由俄罗斯裔科技企业家尤里·米尔纳，以及杰夫·贝佐斯等投资人于2021年出资成立，2022年正式启动运营。
ZW Data Action Technologies Inc.（股票代码CNET）是一家中国本土科技企业，专注为电商、消费品、互联网服务等多个领域的企业客户提供整合数字营销解决方案、大数据分析服务及智能运营工具，助力客户优化获客效率，提升运营水平，推进数字化转型。
BIOA vs CNET — 直观对比
营收规模更大
BIOA
是对方的1.8倍
$1.7M
净利率更高
CNET
高出836.6%
-842.9%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.1M | $1.7M |
| 净利润 | $-25.9M | $-108.0K |
| 毛利率 | — | 5.7% |
| 营业利润率 | -923.4% | -8.9% |
| 净利率 | -842.9% | -6.3% |
| 营收同比 | — | -47.0% |
| 净利润同比 | — | 94.4% |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOACNET
| Q4 25 | $3.1M | — | ||
| Q3 25 | $2.1M | $1.7M | ||
| Q2 25 | $2.4M | — | ||
| Q1 25 | $1.5M | $1.7M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | $0 | $3.2M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $3.5M |
净利润BIOACNET
| Q4 25 | $-25.9M | — | ||
| Q3 25 | $-20.2M | $-108.0K | ||
| Q2 25 | $-21.6M | — | ||
| Q1 25 | $-12.9M | $-531.0K | ||
| Q4 24 | — | $-781.0K | ||
| Q3 24 | $-23.4M | $-1.9M | ||
| Q2 24 | — | $-216.0K | ||
| Q1 24 | — | $-850.0K |
毛利率BIOACNET
| Q4 25 | — | — | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.7% | ||
| Q4 24 | — | -0.4% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 2.0% |
营业利润率BIOACNET
| Q4 25 | -923.4% | — | ||
| Q3 25 | -1126.6% | -8.9% | ||
| Q2 25 | -1027.0% | — | ||
| Q1 25 | -1133.4% | -35.0% | ||
| Q4 24 | — | -24.1% | ||
| Q3 24 | — | -61.5% | ||
| Q2 24 | — | -4.7% | ||
| Q1 24 | — | -26.1% |
净利率BIOACNET
| Q4 25 | -842.9% | — | ||
| Q3 25 | -982.0% | -6.3% | ||
| Q2 25 | -894.0% | — | ||
| Q1 25 | -891.0% | -32.1% | ||
| Q4 24 | — | -34.7% | ||
| Q3 24 | — | -59.1% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | — | -24.1% |
每股收益（稀释后）BIOACNET
| Q4 25 | $-0.72 | — | ||
| Q3 25 | $-0.56 | — | ||
| Q2 25 | $-0.60 | — | ||
| Q1 25 | $-0.36 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.70 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $281.1M | $1.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $272.1M | $3.3M |
| 总资产 | $294.9M | $9.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIOACNET
| Q4 25 | $281.1M | — | ||
| Q3 25 | $285.8M | $1.8M | ||
| Q2 25 | $297.3M | — | ||
| Q1 25 | $320.5M | $807.0K | ||
| Q4 24 | — | $812.0K | ||
| Q3 24 | $334.5M | $1.1M | ||
| Q2 24 | — | $510.0K | ||
| Q1 24 | — | $467.0K |
总债务BIOACNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BIOACNET
| Q4 25 | $272.1M | — | ||
| Q3 25 | $277.5M | $3.3M | ||
| Q2 25 | $294.8M | — | ||
| Q1 25 | $313.2M | $3.1M | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | $313.7M | $4.8M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $5.4M |
总资产BIOACNET
| Q4 25 | $294.9M | — | ||
| Q3 25 | $305.1M | $9.7M | ||
| Q2 25 | $322.1M | — | ||
| Q1 25 | $343.8M | $9.5M | ||
| Q4 24 | — | $9.7M | ||
| Q3 24 | $337.4M | $11.0M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | — | $11.4M |
负债/权益比BIOACNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.02× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.03× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-28.3M | $-482.0K |
| 自由现金流经营现金流 - 资本支出 | $-28.4M | — |
| 自由现金流率自由现金流/营收 | -921.5% | — |
| 资本支出强度资本支出/营收 | 3.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-82.3M | — |
8季度趋势，按日历期对齐
经营现金流BIOACNET
| Q4 25 | $-28.3M | — | ||
| Q3 25 | $-16.0M | $-482.0K | ||
| Q2 25 | $-20.0M | — | ||
| Q1 25 | $-17.4M | $-984.0K | ||
| Q4 24 | — | $-830.0K | ||
| Q3 24 | — | $-198.0K | ||
| Q2 24 | — | $-677.0K | ||
| Q1 24 | — | $-353.0K |
自由现金流BIOACNET
| Q4 25 | $-28.4M | — | ||
| Q3 25 | $-16.1M | — | ||
| Q2 25 | $-20.1M | — | ||
| Q1 25 | $-17.8M | $-1.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率BIOACNET
| Q4 25 | -921.5% | — | ||
| Q3 25 | -782.2% | — | ||
| Q2 25 | -834.5% | — | ||
| Q1 25 | -1226.0% | -61.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度BIOACNET
| Q4 25 | 3.6% | — | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 29.4% | 2.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIOA
暂无分部数据
CNET
| Online Advertising Placement | $1.6M | 95% |
| Other | $83.0K | 5% |
